Vimta Labs Limited (BSE: 524394)
Health Care · Life Sciences Tools & Services · IN
Rs537.15
-7.97% today · -24.3% 1Y
Vimta Labs Limited (BSE: 524394) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $248.09M.
Over the last twelve months the share price has lost 24.3%, trading between 377.30 and 737.25.
Tweenvest scores Vimta Labs Limited across four factors: quality 80/100, value 27/100, growth 78/100, dividend 68/100. Its strongest factor is quality.
524394 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $248.09M
- Revenue (TTM)
- $44.55M
- P/E
- 30.43
- EPS
- 17.65
- Dividend yield
- 0.37%
- Beta (5Y)
- -0.10
- 52-week high
- Rs737.25
- 52-week low
- Rs377.30
- Avg volume (3M)
- —
- Shares outstanding
- 44.70M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Frontage Holdings CorporationSEHK: 1521 | $286.41M | HK$1.11 | -6.36% |
| Nautilus Biotechnology, Inc.NasdaqCM: NAUT | $286.32M | $1.96 | -12.89% |
| Standard BioTools Inc.NasdaqGS: LAB | $270.64M | $0.66 | -4.99% |
| Penetrium Bioscience Inc.KOSDAQ: A187660 | $257.45M | ₩6,320.00 | -9.97% |
| Lifecore Biomedical, Inc.NasdaqGS: LFCR | $244.15M | $6.45 | -0.08% |
| Dishman Carbogen Amcis LimitedNSEI: DCAL | $242.48M | Rs149.68 | -0.45% |
| Diaceutics PLCAIM: DXRX | $228.03M | £2.03 | -0.25% |
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
Figures last refreshed Oct 11, 2026.